جستجوی استاد راهنمای دانشگاهی

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +۵ مورد دیگر

Thomas Michaels is an Assistant Professor at the Department of Biology, ETH Zürich, leading the Michaels Group . His research focuses on theoretical models of biomolecular condensates and protein aggregation in biological systems. Research Themes : Protein aggregation, liquid-liquid phase separation, membrane biophysics, and the role of condensates in neurodegenerative diseases like Alzheimer’s and Parkinson’s. Collaborative Approach : Integrates theoretical physics, control theory, and computational biology with experimental validation to design therapeutic strategies. Recent Publications highlight his work on amyloid formation mechanisms, lipid interactions, and phase-separated compartments as biochemical reactors. His group trains PhD students in systems biology and biocondensate physics.

• Soft Matter Physics
• Living Matter Physics
• Protein Aggregation
• +۵ مورد دیگر

Cristian Gómez Canela is a Full Professor in the Department of Analytical and Applied Chemistry at the School of Engineering, Ramon Llull University (IQS). He serves as Coordinator of the Master's Degree in Analytical Chemistry and is an active member of the Catalan Chemical Society (SCQ), representing SCQ in EuChems-EYCN. His academic journey includes a PhD in Chemistry from the University of Barcelona (2014), followed by postdoctoral research at IDAEA-CSIC and King's College University. Dr. Gómez Canela's research focuses on environmental analytical chemistry, particularly the optimization and validation of analytical methods based on liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and high-resolution mass spectrometry (HRMS) for determining organic pollutants in environmental samples. His work extends to metabolomics applied to aquatic organisms and the analysis of neurotoxic compounds in water systems. His research fingerprint reveals strong expertise in zebrafish models (100%), neurotransmitter analysis (66%), Daphnia magna studies (64%), and neurotoxicity assessment (21%). His recent publications (2024-2025) demonstrate a clear trend toward environmental neurotoxicology, with emphasis on the effects of pharmaceuticals and industrial pollutants on aquatic organisms. His work integrates advanced analytical techniques with biological endpoints to assess environmental risks, particularly focusing on neurological and cardiovascular impacts. The research spans method development for pollutant detection, environmental monitoring, and mechanistic studies of neurotoxic effects. Dr. Gómez Canela leads multiple significant research projects including CHEMIPARK (2024-2027) on passive sampling methodologies for environmental pollutants, GESPA (2022-2025) as part of the Environmental Process Engineering and Simulation Group, and several projects on neuroactive compounds in water systems. He has an impressive research output with 91 scientific publications from 2011-2025 and an h-index of 27 with over 2,000 citations. As a dedicated educator, he contributes to multiple academic programs including the Master in Analytical Chemistry, Master in Pharmaceutical Chemistry, and undergraduate degrees in Chemistry and Chemical Engineering. His research group GESPA represents a multidisciplinary team combining chemical engineering, biotechnology, and chemical analysis to advance environmental sustainability through theoretical and experimental approaches.

• Environmental Chemistry
• Analytical Chemistry
• Mass Spectrometry
• +۵ مورد دیگر

Takako Fujioka is an Associate Professor of Music at Stanford University, affiliated with the Center for Computer Research in Music and Acoustics (CCRMA). Her research focuses on the neural mechanisms underlying auditory perception, auditory-motor coupling, and music-supported therapy for neurorehabilitation. She holds a Ph.D. in Physiology from the Graduate University for Advanced Studies, Japan, and M.Sc./B.Eng. degrees in Electrical Engineering from Waseda University. Her work combines neurophysiological techniques such as MEG and EEG to study brain plasticity in development, aging, and stroke recovery. Notable contributions include investigating how music influences motor and cognitive recovery in stroke patients, as well as exploring the neural basis of musical perception through rhythmic synchronization and pitch discrimination studies. Supported by awards from the Canadian Institutes of Health Research during her postdoctoral work at the Rotman Research Institute, her research bridges clinical neuroscience and music cognition. Dr. Fujioka’s expertise spans auditory neuroscience, neurorehabilitation, and technology-assisted music therapy. She has pioneered studies on tactile mapping for cochlear implant users and networked music performance systems, emphasizing cross-modal perception and human-technology interaction. Her findings contribute to both theoretical understanding of auditory processing and practical applications in medical and educational settings. Awards: Canadian Institutes of Health Research Awards (postdoctoral phase) Labs/Teams: CCRMA, Stanford Music Perception Laboratory, Rotman Research Institute collaborations Key Themes: Neuroplasticity, Music-Mediated Rehabilitation, Auditory-Motor Integration, Multisensory Processing Her recent work examines aging-related changes in binaural hearing and the role of beta/gamma oscillations in rhythmic processing. She advocates for translational research that connects neural mechanisms with real-world therapeutic interventions.

• Auditory Perception
• Neural Oscillations
• Auditory-Motor Coupling
• +۵ مورد دیگر

Dewey G. McCafferty is Professor of Chemistry at Duke University with appointments in Biochemistry and the Duke Cancer Institute. His research focuses on chemical biology of chromatin-modifying enzymes and ubiquitin signaling pathways relevant to neurodegeneration and infection. Notable work includes discovering the lasso peptide antibiotic Arcumycin, characterizing the Nedd4 ubiquitin ligase in Parkinson's disease models, and developing chemoproteomic approaches for target identification. Key contributions include elucidation of the futalosine pathway in Chlamydia infections, mechanisms of CPAF protease in bacterial pathogenesis, and engineering of histone demethylase enzymes. McCafferty received the Eli Lilly Award in Biological Chemistry (2005) and directs NIH-funded projects on ubiquitin ligases in neurodegeneration.

• Chemical Biology
• Chromatin Modification
• Enzymology
• +۳ مورد دیگر

Carina Mallard is Professor of Experimental Perinatal Brain Injury Research and Pro-Vice-Chancellor at the University of Gothenburg since July 2023, where she oversees research infrastructure and chairs the Research Board. She previously served as Deputy Vice-Chancellor (2021–2023) and Head of Core Facilities (2018–2021). Her academic career began with a Physiology degree from Lund University and a PhD in Pediatrics at the University of Auckland (1995), followed by a professorship appointment in 2006. Her research focuses on perinatal brain injury , particularly in premature infants , investigating neuroinflammatory mechanisms maternal dietary interventions neurovascular unit dynamics microglia activation long-term consequences of maternal obesity . Recent publications highlight her work on neonatal rodent models , transcriptomic profiling , and anti-inflammatory therapies . Key themes include RNA degradation , mitochondrial protection , and immune-neurovascular interactions . She has supervised 20 doctoral students since 2004 and collaborates internationally with institutions like King's College London. Contact details include two institutional emails and physical addresses across Gothenburg's biomedical campuses. Her leadership roles span research strategy, doctoral education, and EU-level scientific initiatives.

• Perinatal Brain Injury
• Neonatal Neuroscience
• Maternal Nutrition
• +۵ مورد دیگر

David Vocadlo is a Distinguished Professor of Chemistry and Molecular Biology & Biochemistry at Simon Fraser University (SFU), holding the Canada Research Chair in Chemical Biology. His research focuses on Chemical Glycobiology, investigating carbohydrate-processing enzymes and developing chemical tools to study glycan roles in health and disease. His lab explores O-GlcNAc signaling, neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s), and enzyme inhibitors for therapeutic applications. Education: PhD from University of British Columbia (UBC), followed by a CIHR postdoctoral fellowship at UC Berkeley. Key roles include E.W.R. Steacie Memorial Fellow and Royal Society Fellow. Research highlights include O-GlcNAcase inhibitors for neuroprotection, glycan structure-function relationships, and enzyme activity imaging tools. Collaborates globally with experts in glycobiology and employs cutting-edge techniques like chemical synthesis, mass spectrometry, and live-cell imaging. Awards: Distinguished Professor title, Canada Research Chair, Royal Society Fellowship. Active in training researchers through SFU’s graduate programs, emphasizing interdisciplinary approaches. Lab members work on topics ranging from enzyme mechanisms to disease modeling.

• Bioorganic Chemistry
• Chemical Biology
• Glycobiology
• +۳ مورد دیگر

Jessica Williams, PhD is an Assistant Professor in the Department of Neurosciences at the Cleveland Clinic Lerner Research Institute (LRI) with additional faculty appointments at Case Western Reserve University, Kent State University, and Cleveland State University. She serves as the Cleveland Clinic liaison for Kent State University and represents the Clinic on the Executive Council for the Brain Health Institute and the Biomedical Sciences Graduate Program Executive Committee. Education: Postdoctoral Fellowship in Neuroimmunology, Washington University School of Medicine (2017) Ph.D. in Immunology, The Ohio State University (2011) M.S. in Physiology, Purdue University (2006) B.S. in Biology/Chemistry, Lindenwood University (2004) Dr. Williams' research focuses on neuroimmune interactions during multiple sclerosis, particularly examining regional responses of CNS glia to immune stimuli and astrocyte-immune crosstalk. Her lab employs murine MS models, primary human and murine cell analyses, and MS patient lesion assessment to investigate cytokine-mediated neuroprotection and CNS repair mechanisms. Recent work highlights protective astrocyte functions mediated by traditionally deleterious cytokines. Analysis of her 15 most recent publications reveals consistent focus on neuroimmune crosstalk in MS, with increasing emphasis on astrocyte heterogeneity, cytokine signaling (particularly IFNγ), and novel therapeutic targets like immunoproteasomes. Key themes include regional CNS differences in immune responses, glial cell repair mechanisms, and translating basic findings into potential MS therapies. Scientific Awards: Lerner Research Institute Excellence in Education Award (2022) Mentor of the Year Award (2023) Dr. Williams actively mentors the next generation of scientists as evidenced by her CIMER Trained Mentor certification and the graduation of PhD student Brandon Smith. Her research is supported by significant funding from the NIH, National MS Society, W.M. Keck Foundation, Brain Health Research Institute, and Neurological and Vision Impact Area. She regularly serves on study sections for the NIH, National MS Society, and Department of Defense. The Williams Laboratory investigates the interplay between immune and central nervous systems during MS, with current projects examining cytokine-mediated neuroimmune crosstalk for CNS repair and regionally distinct glial responses to inflammation. The lab employs advanced techniques including murine MS models and primary human cell analyses to identify novel therapeutic pathways for MS patients.

• Neuroimmunology
• Multiple Sclerosis
• Astrocyte Biology
• +۵ مورد دیگر

Lee Yong Lim is a Professor of Pharmaceutics at The University of Western Australia (UWA), leading the Laboratory for Drug Delivery. She specializes in innovative drug delivery systems, particularly for pediatric populations and marine aquaculture. Her work focuses on overcoming medication challenges for children through taste-masked formulations and stable drug-loaded scaffolds for ear diseases. She has secured over $4.5 million in research grants from diverse funding bodies. Education: BSc (Pharmacy) Hons, National University of Singapore PhD, University of Manchester Research: Her team developed a patented chocolate-based formulation for bitter drugs and conducts pediatric trials. Collaborations include WA hospitals for safe compounded medicines and international projects in nanotechnology. Key research areas include pediatric medicinal products, veterinary drug delivery, and sustainable drug formulations aligned with UN SDGs. Grants & Funding: Major supporters include NHMRC, ARC, Telethon, and industry partnerships. Current active grants focus on pre-procedural chewables for children and perioperative analytics. Labs/Teams: Heads the Laboratory for Drug Delivery and collaborates with the Centre for Optimisation of Medicines and Institute for Paediatric Perioperative Excellence.

• Drug Delivery Systems
• Pediatric Medicinal Products
• Taste-Masked Medicines
• +۴ مورد دیگر

Dr. Asma Zaidi is a Professor of Biochemistry at Kansas City University specializing in Parkinson's disease research. Her work investigates the role of plasma membrane Ca2+-ATPase (PMCA) in dopaminergic neuron degeneration. Using human postmortem tissue, cell cultures, and mouse models, her research demonstrates how aging and neurotoxins reduce PMCA function in the substantia nigra, leading to selective neuronal death in Parkinson's. Her findings identify potential therapeutic targets for neuroprotection.

• Parkinson's Disease
• Calcium Signaling
• Dopaminergic Neurons
• +۴ مورد دیگر

Christopher G. Tarolli, MD is an Associate Professor in the Department of Neurology at the University of Rochester School of Medicine and Dentistry. He specializes in movement disorders, particularly Parkinson's disease and Huntington's disease, and serves as Director of the Mind, Brain, Behavior neuroscience course and Associate Program Director of the Adult Neurology Residency Program. His work bridges clinical practice with research in wearable sensor technology, palliative care, and health professions education. MD from SUNY Downstate College of Medicine (2012) Residency & Fellowship at University of Rochester Medical Center (2012-2018) Masters of Science in Health Professions Education (Warner School, UR) Dr. Tarolli's research focuses on novel technologies for neurological assessment, practice-based research in movement disorders, and palliative care models. He has contributed to studies on wearable sensors, remote video-based clinical trials, and symptom burden analysis in Parkinson's and Huntington disease. His work emphasizes patient-centered care and digital health innovation. Recent publications highlight his expertise in: Wearable sensor validation for neurodegenerative diseases Telemedicine applications in Parkinson's disease Palliative care integration across disease trajectories Smartphone-based Huntington's disease monitoring Machine learning for movement disorder severity quantification Quality measures in Parkinson's care Awards include the Herbert W. Mapstone Prize for Excellence in Second Year Teaching and participation in the American Academy of Neurology Emerging Leaders Program. Dr. Tarolli also leads clinical research initiatives and educational programs at the University of Rochester Medical Center.

• Movement Disorders
• Parkinson's Disease
• Huntington's Disease
• +۴ مورد دیگر

Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.

• Sleep Biology
• Neurodevelopment
• Chronic Pain
• +۵ مورد دیگر

Emmanuel Stamatakis is a Professor of Physical Activity, Lifestyle, and Population Health at the University of Sydney's School of Health Sciences (Faculty of Medicine and Health). He holds NHMRC Leadership Fellowships (2021-2025 and 2026-2030) and leads the Charles Perkins Centre's Physical Activity & Exercise Theme. His research focuses on lifestyle behaviors' impacts on cardiometabolic conditions, cancer, and cardiovascular health, using large-scale cohort studies and wearable device data. Key roles include directing the Mackenzie Wearables Research Hub and co-chairing WHO's Physical Activity Guidelines Development Group. Education: PhD from University of Bristol (2003), post-doctoral training at University College London. He leads the ProPASS consortium, involving 45 cohorts with wearable data. Over 460 peer-reviewed publications, including Clarivate's Highly Cited list since 2019. Research interests integrate physical activity, sedentary behavior, and sleep analytics with clinical outcomes. Current projects explore wearables-based measurement innovations, SPAN (sleep-physical activity-nutrition) synergies, and intervention designs for GLP-1 receptor agonist users. Recent articles emphasize VILPA (vigorous intermittent lifestyle physical activity) benefits, sleep-cardiovascular links, and multimodal lifestyle optimization. Awards include Australia's Top Researcher in Sports Medicine and multiple NHMRC grants. Supervises PhD projects on physical activity measurement and intervention design. Active in 50+ peer-reviewed journals and national/international funding bodies.

• Physical Activity Epidemiology
• Public Health
• Cardiometabolic Health
• +۴ مورد دیگر

Katherine J. Franz is a Professor of Chemistry at Duke University, affiliated with the Trinity College of Arts & Sciences and the Duke Cancer Institute. She holds a Ph.D. from MIT (2000) and a B.A. from Wellesley College (1995). Her research focuses on bioinorganic chemistry, particularly metal ion coordination in biological systems, with applications in antimicrobial therapies, cancer metallomics, and neurodegenerative diseases. Key projects include developing prochelators targeting fungal and bacterial pathogens, studying copper's role in antifungal drug efficacy, and designing light-activated metal complexes for controlled drug release. Dr. Franz has received numerous awards including the Camille Dreyfus Teacher-Scholar Award (2009), Sloan Research Fellowship (2008), and the NSF CAREER Award (2005). She leads a lab with 6 current students/mentees and has secured grants from NIH, NSF, and the US-Israel Binational Science Foundation. Her lab's work spans from fundamental metalloprotein studies to translational drug development, emphasizing interdisciplinary approaches in chemistry and biology. Education: Ph.D. in Chemistry, MIT, 2000 B.A. in Chemistry, Wellesley College, 1995 Research Interests: Metal homeostasis in pathogens, copper's role in antifungal resistance, prodrug design for targeted therapy, and mechanistic studies of metalloproteins. Grants: Tri-Institutional Molecular Mycology Training Program (NIH, 2024–2029) Duke PREP Biomedical Sciences Program (NIGMS, 2022–2027) Copper-Mucin Interaction Study (BSF, 2022–2026) Her lab's publications (n=15+ since 2020) highlight breakthroughs in prodrug selectivity, copper-induced protein toxicity, and histatin antifungal mechanisms. The Franz Lab actively collaborates with clinicians and computational scientists to advance therapeutic strategies addressing unmet medical needs in infectious diseases and cancer.

• Bioinorganic Chemistry
• Metal Homeostasis
• Antimicrobial Agents
• +۴ مورد دیگر

Dale L. Boger is a Professor of Chemistry at The Scripps Research Institute (TSRI), where he leads the Boger Group specializing in synthetic organic and medicinal chemistry. His academic roles include serving as co-Chair (2017-2018) and Chairman (2013-2017) of the Chemistry Department. Boger earned his B.S. from the University of Kansas (1975) and Ph.D. from Harvard University (1980). His research focuses on total synthesis of natural products, development of synthetic methodologies, and antibiotic design, particularly addressing antibiotic resistance via glycopeptide analogs like vancomycin. Key honors include the Paul Janssen Prize (2002), RSC Robert Robinson Award (2017), and election to the National Academy of Sciences (2014). His work spans collaborations in bioorganic chemistry, molecular modeling, and drug design. The Boger Group’s lab includes numerous students and postdocs, advancing projects such as maxamycins and guanidine-modified vancomycins. Funding includes NIH grants and industry partnerships, highlighting his contributions to both academic and applied research. Research highlights include groundbreaking studies on vancomycin analogs with dual mechanisms of action to combat resistance, as well as contributions to TLR agonists and neurovascular drug delivery. His legacy includes over 300 publications and impactful patents in antibiotic design and synthetic organic chemistry.

• Synthetic Organic Chemistry
• Chemical Biology
• Bioorganic Chemistry
• +۴ مورد دیگر